US 10736975
Infusion administration of conjugated monoclonal antibodies
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10736975 (Infusion administration of conjugated monoclonal antibodies) held by Actinium Phamaceuticals, Inc. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Actinium Phamaceuticals, Inc.
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/427